“showed a trend”

The impaired patients showed a trend toward significance for more errors than zero in the no distracter condition, t (5) = 2.23, p = 0.076, with three out of six patients making at least one error.

Nevertheless the survival of the patients with a right sided tumor and a higher dose (Q m 4) to the ipsilateral hippocampus showed a trend towards increased survival compared to patients with a low dose (Q m 1) (log-rank: p = 0.076) (Figure 2 ).

In patients with luminal-A cancers, c-Nectin-4 status was an independent predictor of DFS (HR =.3.5: 95% CI, 1.1–11.6; P =0.038), while it showed a trend toward statistical significance for LRFS (HR=3.9: 95% CI, 0.9–17.6; P =0.076) ( Table 3 ).

Additionally, post hoc analyses revealed the following relationships between mass and wound size within family on either Day 6 or Day 10 of wound-healing; Family B showed a trend toward a positive relationship between mass and wound size on Day 10 during both X 1 ( F 1,7 = 5.68, P = 0.076, estimate = 0.27) and X 2 ( F 1,7 = 4.72, P = 0.066); all other relationships were non-significant (all F 1,7 < 1.54, all P > 0.25, -0.16 < all estimates < 0.12).

Bonferroni post hoc comparisons revealed the main differences between the groups for behavioural disengagement showed a trend towards higher behavioural disengagement in monthly leakers compared to infrequent leakers ( p = 0.076).

Results Patients with abnormal levels of S100β showed a trend towards higher delirium duration ( P =0.076); Group B (standard deviation) (7.0 [3.2] days), Group C (5.5 [6.3] days), and Group D (5.3 [6.0] days), compared to patients in Group A (3.5 [5.4] days).

Surgical time exceeding 4 h showed a trend toward higher risk (OR = 1.87, 95% CI: 0.94–3.75, P = 0.076), while anesthesia time greater than 4 h was significantly associated with elevated risk (OR = 2.97, 95% CI: 1.44–6.12, P = 0.003).

In Vp4 PVTT patients, pre-PSM analysis showed a trend toward improved survival in the HTP group (13.3 vs. 11.4 months; HR=0.64; 95% CI: 0.39-1.05; P =0.076), which became statistically significant post-PSM (15.3 vs. 9.3 months; HR=0.51; 95% CI: 0.26-0.98; P =0.040).

The interaction showed a trend-level effect ( β = −0.225, p = 0.076; index of moderated mediation = −0.058, bootstrapped 95% CI =[−0.140, 0.009]; Figure S5a ), suggesting potential variation in the coupling–memory relationship across PSQI levels.

The HF power spectrum did not change in any period in SC horses, although it showed a trend to decrease during P1-rd ( P = 0.0761) and P2-rd ( P = 0.0789).

Over the course of the 7-day treatment period, 5% diacerein and placebo application showed a trend towards decreased scaling ( p = 0.0762 and p = 0.0747, respectively), while application of 2.5% and 10% diacerein diminished the scaling scores ( p = 0.0076 and p = 0.0161, respectively) compared to untreated IMQ-induced psoriasis.

In TCGA database, the Kaplan-Meier survival curve for lung adenocarcinoma patients showed a trend toward poorer survival in H63D HFE variants compared to WT HFE patients (p = 0.0763) ( Fig 3A ).

Results The primary endpoint showed a trend ( p = 0.0767) with a mean treatment effect of −0.12 (95% CI, −0.3 to 0) toward a favorable change in mean CSMS(n) for active compared to placebo treatment.

The percentage of NK cells showed a trend toward a decrease in ovaries from Asc −/− mice compared to WT mice ( p = 0.0767) ( Figures 4E,F ).

All experiments showed a trend towards a reduced expression of Ki-67 in Tat 101 cells, compared to Tet off (p=0.0769) ( Figure 1E ).

Furthermore, protein expression of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α), a transcriptional coactivator that plays a key role in regulating a number of genes involved in energy metabolism ( 18 ), showed a trend toward a reduction in control-treated DIO mice ( P = 0.077) that was not apparent in myriocin-treated DIO mice ( Fig. 4 E ).

However, PED showed a trend towards better complete occlusion over a median 8-month angiographic follow-up (81.8% vs 75.3%, P=0.077).

Moreover, LF% during the AW stage showed a trend of a positive correlation with cognitive performance for all mice at the early stage (r = 0.441, p = 0.077) and APP/PS1 at the early stage alone (r = 0.566, p = 0.070).

Elderly patients showed a trend towards increased LOS (17.3 vs. 14.1 days; p = 0.077) and nosocomial infection rates (30% vs. 24%; p = 0.15), though these did not reach statistical significance.

High MYO18B methylation showed a trend towards better response (PFS: HR = 0.67 (0.43–1.04), P = 0.077) but no association with overall survival (Additional file 3 : Figure S5A, B).

In younger patients (< 65 years), only T2DM (HR = 1.47, 95% CI: 1.10–1.97, p = 0.009) was significant, while SIDM showed a trend (HR = 1.22, 95% CI: 0.98–1.52, p = 0.077).

Our TEG results showed that there were no significant differences in naïve whole blood when compared with whole blood samples with added TNF-α; although the R-time showed a trend towards a faster clotting initiation time (p = 0.077).

The VSP group showed a trend of GMV decrease in the left middle temporal cortex compared with that in the nVSP group (p = 0.077).

Moreover, the change in the horizontal extent of RORA correlated with the change in the horizontal extent of OPL deterioration (R = 0.307, P = 0.026; Fig 2 C), whereas the relationship showed a trend in the vertical section (R = 0.252, P = 0.077; Fig 2 D).

The laser guide group showed a trend of small error than that in the conventional group (p = 0.077).